TITLE

After Thalidomide

AUTHOR(S)
Sheridan, Mary D.
PUB. DATE
December 1970
SOURCE
British Medical Journal;12/26/1970, Vol. 4 Issue 5738, p792
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
64098840

 

Related Articles

  • Thalidomide.  // Reactions Weekly;2/7/2009, Issue 1238, p33 

    The article describes the case of a 24-year-old man who developed constant urinary incontinence after receiving thalidomide for Behçet's disease. The patient received 200 milligrams of thalidomide a day. Five days after thalidomide administration, he complained of urinary incontinence....

  • First report of multiple myeloma dedifferentiation: 4 case reports.  // Reactions Weekly;5/22/2004, Issue 1002, p14 

    Discusses research being done on the occurrence of plasma cell differentiation during treatment with thalidomide for multiple myeloma. Reference to a study by E. Balleari et al, published in the April 2004 issue of the "Leukemia and Lymphoma"; Dosage of thalidomide received by each patient;...

  • Thalidomide Is Back. Wright, Karen // Discover;Apr2000, Vol. 21 Issue 4, p31 

    Reports on the reintroduction of the controversial drug thalidomide in the United States in July 1998 to treat a debilitating complication of leprosy. Market withdrawal of the drug in the 1960s after its use was linked to a number of birth deformities; Potential use of thalidomide in treating...

  • Thalidomide.  // Reactions Weekly;11/10/2007, Issue 1177, p27 

    The article describes the case of a man who developed thrombocytopenia during treatment with thalidomide for multiple myeloma. The components of the induction chemotherapy received by the patient include bortezomib and dexamethasone. The patient's platelet count increased after thalidomide was...

  • Thalidomide.  // Reactions Weekly;1/21/2006, Issue 1085, p26 

    The article presents a case report involving an elderly patient who developed thrombocytopenia during treatment with thalidomide for multiple myeloma. Laboratory results before and after thalidomide treatment are presented.

  • Thalidomide withdrawal.  // Reactions Weekly;9/25/2010, Issue 1320, p43 

    The article describes the cases of four patients who experienced a leprosy type 2 reaction after withdrawal of thalidomide.

  • Thalidomide.  // Reactions Weekly;11/6/2010, Issue 1326, p32 

    The article describes the case of a man who developed fifth aortic arch and bony deformities after in utero exposure to thalidomide.

  • Response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromes. Candoni, A.; Raza, A.; Silvestri, F.; Lisak, L.; Galili, N.; Mumtaz, M.; Kikic, F.; Fanin, R. // Annals of Hematology;Jul2005, Vol. 84 Issue 7, p479 

    Presents a letter to the editor reporting response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromes.

  • Thalidomide.  // Reactions Weekly;9/17/2011, Issue 1369, p36 

    The article describes the case of a woman who developed various toxicities after treatment with thalidomide for familial primary cutaneous amyloidosis.

  • Thalidomide.  // Reactions Weekly;Dec2015, Vol. 1580 Issue 1, p326 

    The article describes the case of a 69-year-old male patient who developed hypothyroidism after taking thalidomide.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics